- Home
- / Armata Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Armata Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$2.3
2024-10-29
Market Capitalization
$84 M
2024-10-29
Revenue
$409 K
FY, 2014
CreditSafe Score
?
Score changed on May 12, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 409.0K | ||||||||||
| General and administrative expense | 6.9M | 6.4M | 8.4M | 7.6M | 5.7M | 9.3M | 8.0M | 8.3M | 7.4M | 11.6M | 13.2M |
| Operating expense total | 12.7M | 10.4M | 14.1M | 10.5M | 10.6M | 19.1M | 22.4M | 42.5M | 47.6M | ||
| EBIT | (14.1M) | (10.2M) | (23.4M) | (16.2M) | (12.5M) | (19.8M) | (21.6M) | (23.8M) | (36.9M) | (40.9M) | (42.4M) |
| EBIT margin, % | -3449.9% | ||||||||||
| Interest income | 6.0K | 96.0K | 28.0K | 5.0K | 29.0K | 179.0K | |||||
| Interest expense | 2.6M | ||||||||||
| Pre tax profit | (589.0K) | (19.4M) | (14.1M) | (12.4M) | (19.5M) | (22.2M) | (23.2M) | (36.9M) | (69.0K) | (18.9M) | |
| Income tax expense | (73.0K) | (556.0K) | (1.3M) | (328.0K) | |||||||
| Net Income | 23.1M | (516.0K) | (18.8M) | (12.8M) | (12.1M) | (19.5M) | (22.2M) | (23.2M) | (36.9M) | (69.0M) | (18.9M) |
| EPS | (1.1) | (1.0) | (0.9) |